Page last updated: 2024-09-03

tyrosyl-arginyl-phenylalanyl-lysinamide and enkephalin, ser(2), leu(5), thr(6)-

tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with enkephalin, ser(2), leu(5), thr(6)- in 1 studies

Compound Research Comparison

Studies
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Trials
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Recent Studies (post-2010)
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Studies
(enkephalin, ser(2), leu(5), thr(6)-)
Trials
(enkephalin, ser(2), leu(5), thr(6)-)
Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-)
7401722405

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lishmanov, IuB; Maslov, LN; Rebrova, TIu; Tam, SV1

Other Studies

1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and enkephalin, ser(2), leu(5), thr(6)-

ArticleYear
[The role of mu- and delta-opiate receptors in resistance of the myocardium to free radical damage].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2001, Volume: 87, Issue:5

    Topics: Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Free Radicals; In Vitro Techniques; Lipid Peroxidation; Myocardial Contraction; Myocardium; Oligopeptides; Oxidative Stress; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu

2001